Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1016/j.jcin.2021.02.022

Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial

..., Investigators
1
Volume: 14, Issue: 7, Pages: 768 - 780
Published: Apr 1, 2021
Abstract
The aim of this study was to explore the early versus late benefits and risks of dabigatran dual therapy versus warfarin triple therapy in the RE-DUAL PCI (Randomized Evaluation of Dual Antithrombotic Therapy With Dabigatran Versus Triple Therapy With Warfarin in Patients With Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention) trial.Patients with atrial fibrillation who undergo percutaneous coronary intervention are...
Paper Fields
Paper Details
Title
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
DOI
doi.org/10.1016/j.jcin.2021.02.022
Published Date
Apr 1, 2021
Volume
14
Issue
7
Pages
768 - 780
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.